4D Pharma: New data early indication LBPs may help to overcome resistance to checkpoint inhibitors

The latest results in an ongoing study are a ‘step forward’ for one of 4D Pharma’s live biotherapeutics (LBPs). The findings underscore the increasing importance of the microbiome in cancer treatment, says the chief executive.